Literature DB >> 18930143

The endocannabinoid system is modulated in response to spinal cord injury in rats.

Daniel Garcia-Ovejero1, Angel Arevalo-Martin, Stefania Petrosino, Fabian Docagne, Carlos Hagen, Tiziana Bisogno, Masahiko Watanabe, Carmen Guaza, Vincenzo Di Marzo, Eduardo Molina-Holgado.   

Abstract

Endocannabinoids are lipid mediators with protective effects in many diseases of the nervous system. We have studied the modulation of the endocannabinoid system after a spinal cord contusion in rats. In early stages, lesion induced increases of anandamide and palmitoylethanolamide (PEA) levels, an upregulation of the synthesizing enzyme NAPE-phospholipase D and a downregulation of the degradative enzyme FAAH. In delayed stages, lesion induced increases in 2-arachidonoylglycerol and a strong upregulation of the synthesizing enzyme DAGL-alpha, that is expressed by neurons, astrocytes and immune infiltrates. The degradative enzyme MAGL was also moderately increased but only 7 days after the lesion. We have studied the cellular targets for the newly formed endocannabinoids using RT-PCR and immunohistochemistry against CB(1) and CB(2) receptors. We observed that CB(1) was constitutively expressed by neurons and oligodendrocytes and induced in reactive astrocytes. CB(2) receptor was strongly upregulated after lesion, and mostly expressed by immune infiltrates and astrocytes. The endocannabinoid system may represent an interesting target for new therapeutical approaches to spinal cord injury.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18930143     DOI: 10.1016/j.nbd.2008.09.015

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  42 in total

1.  Activation of spinal and supraspinal cannabinoid-1 receptors leads to antinociception in a rat model of neuropathic spinal cord injury pain.

Authors:  Aldric Hama; Jacqueline Sagen
Journal:  Brain Res       Date:  2011-07-26       Impact factor: 3.252

Review 2.  The endocannabinoid system and pain.

Authors:  Josée Guindon; Andrea G Hohmann
Journal:  CNS Neurol Disord Drug Targets       Date:  2009-12       Impact factor: 4.388

Review 3.  Neuroprotection in Oxidative Stress-Related Neurodegenerative Diseases: Role of Endocannabinoid System Modulation.

Authors:  Janos Paloczi; Zoltan V Varga; George Hasko; Pal Pacher
Journal:  Antioxid Redox Signal       Date:  2017-07-18       Impact factor: 8.401

Review 4.  Effect of endocannabinoid signalling on cell fate: life, death, differentiation and proliferation of brain cells.

Authors:  Moises Garcia-Arencibia; Eduardo Molina-Holgado; Francisco Molina-Holgado
Journal:  Br J Pharmacol       Date:  2018-06-22       Impact factor: 8.739

5.  Identification of prostamides, fatty acyl ethanolamines, and their biosynthetic precursors in rabbit cornea.

Authors:  Paula Urquhart; Jenny Wang; David F Woodward; Anna Nicolaou
Journal:  J Lipid Res       Date:  2015-05-31       Impact factor: 5.922

6.  Neuroprotective Effect of JZL184 in MPP(+)-Treated SH-SY5Y Cells Through CB2 Receptors.

Authors:  María S Aymerich; Estefanía Rojo-Bustamante; Carmen Molina; Marta Celorrio; Juan A Sánchez-Arias; Rafael Franco
Journal:  Mol Neurobiol       Date:  2015-05-15       Impact factor: 5.590

7.  Isolevuglandin-modified phosphatidylethanolamine is metabolized by NAPE-hydrolyzing phospholipase D.

Authors:  Lilu Guo; Stephen D Gragg; Zhongyi Chen; Yongqin Zhang; Venkataraman Amarnath; Sean S Davies
Journal:  J Lipid Res       Date:  2013-09-09       Impact factor: 5.922

Review 8.  The endocannabinoid system as a target for the treatment of neurodegenerative disease.

Authors:  Emma L Scotter; Mary E Abood; Michelle Glass
Journal:  Br J Pharmacol       Date:  2010-06       Impact factor: 8.739

9.  Cannabinoid receptor agonists modulate oligodendrocyte differentiation by activating PI3K/Akt and the mammalian target of rapamycin (mTOR) pathways.

Authors:  O Gomez; A Sanchez-Rodriguez; Mqu Le; C Sanchez-Caro; F Molina-Holgado; E Molina-Holgado
Journal:  Br J Pharmacol       Date:  2011-08       Impact factor: 8.739

10.  Metabolomics uncovers dietary omega-3 fatty acid-derived metabolites implicated in anti-nociceptive responses after experimental spinal cord injury.

Authors:  J D Figueroa; K Cordero; M Serrano-Illan; A Almeyda; K Baldeosingh; F G Almaguel; M De Leon
Journal:  Neuroscience       Date:  2013-09-14       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.